The Broad Institute, American Empire.
"Zhang Feng, you did a great job this time. The shareholders are very satisfied. You're definitely going to win the Nobel Prize this year."
Church, the director of the Broad Institute, patted Zhang Feng on the shoulder, his eyes filled with excitement.
After all, everyone can see the future potential of 'Bode-001, an effective drug for AIDS'.
It's safe to say they could make hundreds of billions of dollars just from this miracle drug!
But soon, Church, the director of the Broad Institute, looked grim, and he sighed and said:
"It's a pity that Lin Feng doesn't understand business tactics."
His 'EBT-002 gene therapy' can slightly modify a patient's genes, allowing them to be immune to AIDS virus for life after treatment.
This behavior is a disgrace to the pharmaceutical industry. His actions have essentially cut off the future profit-making opportunities related to AIDS; it's utterly unforgivable!
There is an unwritten rule in the global pharmaceutical industry that drugs developed should not be too effective.
For example, a normal person can perfectly treat their disease by taking a dose of medicine with 100% of its efficacy.
After that, pharmaceutical companies would voluntarily reduce the efficacy of drugs under an unwritten rule.
The efficacy of a drug that is 100% effective is reduced to 5% or 7% of its effectiveness, achieving a certain effect but not being able to cure the disease immediately.
The ultimate goal of doing this is to get patients to buy more medicine.
After all, if a patient is cured after taking the medicine once, then the patient will definitely not buy the medicine again.
The number of patients is limited. Given that the number of patients cannot be increased significantly, pharmaceutical companies can only try their best to make as much money as possible from the limited number of patients.
This is the unwritten rule in the global pharmaceutical industry.
Therefore, the global pharmaceutical industry actually dislikes and abhors those highly effective drugs that can hit the mark immediately.
In particular, I find Lin Feng's gene therapy drugs, which supposedly grant patients lifelong immunity, utterly repulsive.
For them, the best-case scenario is that you take medication every day, which can suppress the symptoms but not cure them immediately. That's the best-case scenario.
Because in this way, patients will keep buying medicine, contributing profits to pharmaceutical companies, and ultimately draining patients' savings and lives.
The 'EBT-002 gene therapy drug' launched by Xingtu Gene Company can not only cure AIDS with one injection, but also make people immune to AIDS for life.
This is tantamount to uprooting the source of everyone's ability to make money, which naturally incurred public wrath.
As a result, more than two months have passed, and the 'EBT-002 gene therapy drug' still cannot undergo clinical trials, and the day it is launched on the market is still far away.
The reason for all this is that pharmaceutical companies in various overseas countries are all trying their best to sabotage Xingtu Gene Company and hinder Xingtu Gene Company progress.
"Director Qiu, Lin Feng is an incredibly foolish person when it comes to business."
His biggest mistake wasn't developing a cure for AIDS, but rather making people immune to AIDS for life, which angered the public.
"Haha, great minds think alike."
Upon hearing this, Church, the director of the Broad Institute, laughed heartily and then said:
"Lin Feng's act of making people immune to AIDS for life has successfully aroused the hostility of pharmaceutical companies of all sizes around the world."
To be honest, in order to punish Xingtu Gene Company that broke the unspoken rules, pharmaceutical companies around the world have been secretly putting pressure on local Medical Bureau.
The approval process for Xingtu Gene Company's 'EBT-002 gene therapy drug' should be followed according to the standard procedure, without expediting the approval process.
Ultimately, it takes six months for approval before clinical trials can begin, followed by six months of continuous clinical trials, and finally a year before the product can be officially launched.
This also means that when Xingtu Gene Company's 'EBT-002 gene therapy drug' was launched, our 'Bode-001 AIDS treatment drug' had already been on the market for more than 9 months.
During these nine months, all patients who could be treated for AIDS received treatment; those who could not were either poor or unwilling to spend money.
This means we've consumed the equivalent of 25 million out of 390 million people living with AIDS —three-quarters of the population...
"This is all thanks to you, Zhang Feng. You deserve the Nobel Prize."
After speaking, Church, the director of the Broad Institute, was also quite excited and spoke much more than before.
After all, once you've made a lot of money, everyone will talk more and want to share their joy with others.
"It's all thanks to Director Church's support."
Zhang Feng was pleased to be praised twice in a row, but traditional Chinese cultural education still made him speak modestly.
Upon hearing this, Qiu Qi smiled and said:
"After Lin Feng developed the Gene Enhancement Potion, the American Empire military also wanted to develop its own Gene Enhancement Potion."
However, the military currently cannot afford much funding; the maximum investment is only one billion US dollars.
Therefore, in the end, we still have to rely on our own research and development, and only when we achieve results will the military make large-scale purchases of Gene Enhancement Potion.
Are you confident that you can develop your own Gene Enhancement Potion?
"Gene Enhancement Potion? It's impossible to develop such a Gene Enhancement Potion within the next twenty years."
However, if we continue to use human lives to accumulate experience as before, and have thousands of researchers dedicated to developing Gene Enhancement Potion...
There is still a sliver of hope that First-generation Gene Enhancement Potion can be developed within five years, and then upgraded to Second-generation Gene Enhancement Potion within ten years.
Zhang Feng gave his reply.
After all, he knew his own family best. As the pioneer of CRISPR/Cas9 Gene Editing Technology in the West, he knew all too well how advanced and miraculous the Gene Enhancement Potion technology that Lin Feng had developed was.
To achieve the same effect as the Gene Enhancement Potion in the video, one must have a thorough understanding and mastery of every segment of the human genome.
If you don't understand the mysteries of the human genome and forcibly transplant a segment of someone's genes, death due to genetic conflict is an inevitable outcome.
This requires experimenting with a huge number of lives and figuring out why the experimenters died.
Even if you overcome the transplantation and replacement of one gene segment, what happens if a second gene segment is added?
The test subject will still die, and you will still need to find the cause and then overcome the reason that caused the test subject to die.
This constant cycle of failure and success requires the expenditure of a huge number of lives as a price.
Although monkeys can be used as test subjects in the early stages, humans must be used as test subjects later.
Because monkeys will always be monkeys, and humans will always be humans; they are ultimately two different kinds of beings.
Therefore, if the successful experiences of monkeys are applied to humans, many of those experiences will become obsolete.
Ultimately, the reality is that a huge number of lives still need to be used as experimental subjects.
"Thousands of researchers, no expense spared in conducting human experiments, and a minimum of 5 years of research and development time?"
Upon hearing Zhang Feng's words, Qiu Qi, the director of the Broad Institute, twitched at the corner of his mouth.